Celltrion, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the first and only biosimilar designated as interchangeable ...

Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels. The ...

Adults can take 25 to 50 milligrams of Benadryl every four to six hours as needed. Children 6 to 11 should take 12.5 to 25 milligrams of Benadryl every four to six hours as needed. Adults can take 25 ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...

Ozempic is an injectable medication used once a week to help manage type 2 diabetes. The starting dose for Ozempic is 0.25 milligrams (mg) per week, which increases to 0.5 mg after four weeks. Ozempic ...

Existing research has analyzed CBD dosages and effects ranging from 10 to 1,500 mg daily. Results vary. It’s always best to start small and increase slowly until you reach your desired effect. Your ...

Efgartigimod treatment in gMG patients led to reduced glucocorticoid use, with 26% ceasing use and 66% reducing dosage by at least 1 mg/day after one year. The study observed a decrease in reliance on ...

Outlook of the industry, market trends and key opinions from leaders within the industry ...

Outlook of the industry, market trends and key opinions from leaders within the industry ...

Steqeyma is now supplied as a 45 mg/0.5 mL solution in a single-dose vial for subcutaneous injection for pediatric patients weighing less than 60kg. The new dosage form and strength of Steqeyma allow ...